Association between epicardial adipose tissue and transfusion-dependent β-thalassemia
- PMID: 41065927
- PMCID: PMC12628453
- DOI: 10.1007/s10554-025-03535-2
Association between epicardial adipose tissue and transfusion-dependent β-thalassemia
Abstract
Background: Epicardial adipose tissue (EAT) is a fat depot with secretive and neuromodulative properties, involved in the pathogenesis of cardiovascular diseases. Transfusion-dependent β-thalassemia (TDβT) is an inherited disorder characterized by chronic anemia and at risk for the development of several comorbidities. Patients with TDβT have a higher incidence of cardiovascular diseases compared to the general population.
Methods: The aim of this study was to evaluate EAT thickness in a cohort of patients with TDβT (study group), compared to age- and sex-balanced patients with no TDβT (control group). Secondary endpoint included evaluation of differences in the regional distribution of EAT between patients with or without cardiovascular disease (NCT05508932).
Results: Overall, 272 patients were enrolled, of whom 136 in study group and 136 in control group. EAT thickness was significantly higher in the study group at left atrium, left atrioventricular groove and right atrioventricular groove compared to control group (4.2 vs. 3.0, 12.2 vs. 10.0 and 13.0 vs. 11.0 mm, respectively, p < 0.05 for all). Multivariable analysis confirmed an independent association between EAT and TDβT. The regional distribution of EAT showed significant differences between patients with or without atrial fibrillation, diabetes mellitus, stroke or heart failure.
Conclusions: Patients with TDβT have higher values of EAT compared to controls with no TDβT.
Keywords: Arrhythmia; Atrial fibrillation; Cardiac; Epicardial fat; Hemoglobinopathy; Magnetic resonance.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Conflict of interest: the authors have no conflict of interest to declare.
Figures
References
-
- Kattamis A, Kwiatkowski JL, Aydinok Y, London (2022) England) 399(10343):2310–2324. 10.1016/S0140-6736(22)00536-0 - PubMed
-
- Taher AT, Musallam KM, Cappellini MD (2021) β-Thalassemias. Longo DL, ed. N Engl J Med. ;384(8):727–743. 10.1056/NEJMRA2021838 - PubMed
-
- Forni GL, Gianesin B, Musallam KM et al (2023) Overall and complication-free survival in a large cohort of patients with β-thalassemia major followed over 50 years. Am J Hematol 98(3):381–387. 10.1002/AJH.26798 - PubMed
-
- Taher A, Isma’eel H, Mehio G et al (2006) Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the mediterranean area and Iran. Thromb Haemost 96(4):488–491. 10.1160/TH06-05-0267/ID/JR0267-11 - PubMed
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Medical
